Author:
Jutte N.H.P.M.,Heyse P.,Daane C.R.,Vaessen L.M.B.,Claas F.H.J.,Balk A.H.M.M.,Mochtar B.,Weimar W.
Subject
Transplantation,Immunology,Immunology and Allergy
Reference22 articles.
1. Cyclosporin A: recent developments in the mechanism of action and clinical application;Feutren;Curr Opin Immunol,1989
2. Immune monitoring of heart transplant patients receiving either one or two cycles of OKT3 prophylaxis. Induced anti-idiotypic and anti-isotypic anti-OKT3 antibodies do not inhibit depletion of peripheral T cells due to second OKT3 treatment;Hesse;Clin Transplant,1991
3. Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agent;Vigeral;Transplantation,1986
4. OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties;Van Wauwe;J Immunol,1980
5. Activation of human T cells in vivo following treatment of transplant recipients with OKT3;Ellenhorn;Transplantation,1990